Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41392-022-01007-w.

Title:
mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy
Description:
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent. This represents a rising precision medicine field with great promise for preventing and treating many intractable or genetic diseases. In addition, in vitro transcribed mRNA has achieved programmed production, which is more effective, faster in design and production, as well as more flexible and cost-effective than conventional approaches that may offer. Based on these extraordinary advantages, mRNA vaccines have the characteristics of the swiftest response to large-scale outbreaks of infectious diseases, such as the currently devastating pandemic COVID-19. It has always been the scientists’ desire to improve the stability, immunogenicity, translation efficiency, and delivery system to achieve efficient and safe delivery of mRNA. Excitingly, these scientific dreams have gradually been realized with the rapid, amazing achievements of molecular biology, RNA technology, vaccinology, and nanotechnology. In this review, we comprehensively describe mRNA-based therapeutics, including their principles, manufacture, application, effects, and shortcomings. We also highlight the importance of mRNA optimization and delivery systems in successful mRNA therapeutics and discuss the key challenges and opportunities in developing these tools into powerful and versatile tools to combat many genetic, infectious, cancer, and other refractory diseases.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our calculations suggest that Nature.com earns between $42,042 and $115,616 monthly online from display advertisements.

Keywords {🔍}

mrna, pubmed, article, google, scholar, cas, central, cells, delivery, vaccines, vaccine, protein, rna, cancer, cell, mrnabased, immune, diseases, translation, sarscov, mol, encoding, therapeutics, vivo, nanoparticles, patients, lipid, expression, efficacy, nat, ther, human, response, virus, gene, clinical, including, efficiency, therapeutic, mice, cap, vaccination, immunity, rev, immunotherapy, proteins, dendritic, mrnas, therapy, med,

Topics {✒️}

nature portfolio ionizable cationic lipid/phosphatidylcholine/cholesterol/peg-lipid ionizable cationic lipid/phosphatidylcholine/cholesterol/peg/lipid lipid-varied libraries 5a2-sc8-based dendrimer lnps ss-cleavable proton-activated lipid commercial purification kits ss-cleavable ph-activated lipid privacy policy avoid graft-versus-host reactions recombinant alpha1-antitrypsin fc-fused advertising bnt162b2-immunized sars-cov-1 survivors nod-prkdcscid-il2rγ null mice exon-skipping tricyclo-dna oligomers cationic phema-g-pdmaema polymers methylmalonyl-coa mutase activity crispr-cas gene editing anti-sars-cov-2 antibody mrna-bnt162b2 sars-cov-2 vaccine mrna vaccine-induced neoantigen-specific trivalent nucleoside-modified mrna dlin-mc3-dma-based formulations anti-ctla-4 monoclonal antibody pan-sarbecovirus neutralizing antibodies reprints crispr/cas nuclease system redox-responsive polymer pdsa respiratory syncytial virus 143 dotap/chol/dspe-polyethylene glycol anti-sars-cov-2 antibodies charge-neutralizing intramolecular rearrangement tumor-mrna-transfected dendritic cells open reading frame full-length wild-type regional multidrug-resistant bacterial sepsis sars-cov-2 omicron variant crispr/cas-based methods schumann adopted peg[glu sars-cov-2 exposure history high-efficacy disease-modifying therapies anti-inflammatory cytokine il-10 west china hospital homology-driven genome editing polymer–lipid hybrid nanoparticles factor viii-encoding mrna robust t-cell response recombinant receptor-binding domain αpv1 antibody-encapsulated mrna

Questions {❓}

  • (1) How can mRNA macromolecules be better delivered?
  • CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?
  • Determinants and implications of mRNA poly(A) tail size–does this protein make my tail look big?
  • Will SARS-CoV-2 variants of concern affect the promise of vaccines?
  • MRNA: a novel avenue to antibody therapy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:mRNA-based therapeutics: powerful and versatile tools to combat diseases
         description:The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent. This represents a rising precision medicine field with great promise for preventing and treating many intractable or genetic diseases. In addition, in vitro transcribed mRNA has achieved programmed production, which is more effective, faster in design and production, as well as more flexible and cost-effective than conventional approaches that may offer. Based on these extraordinary advantages, mRNA vaccines have the characteristics of the swiftest response to large-scale outbreaks of infectious diseases, such as the currently devastating pandemic COVID-19. It has always been the scientists’ desire to improve the stability, immunogenicity, translation efficiency, and delivery system to achieve efficient and safe delivery of mRNA. Excitingly, these scientific dreams have gradually been realized with the rapid, amazing achievements of molecular biology, RNA technology, vaccinology, and nanotechnology. In this review, we comprehensively describe mRNA-based therapeutics, including their principles, manufacture, application, effects, and shortcomings. We also highlight the importance of mRNA optimization and delivery systems in successful mRNA therapeutics and discuss the key challenges and opportunities in developing these tools into powerful and versatile tools to combat many genetic, infectious, cancer, and other refractory diseases.
         datePublished:2022-05-21T00:00:00Z
         dateModified:2022-05-21T00:00:00Z
         pageStart:1
         pageEnd:35
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41392-022-01007-w
         keywords:
            Cell biology
            Molecular biology
            Medicine/Public Health
            general
            Internal Medicine
            Cancer Research
            Cell Biology
            Pathology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig9_HTML.png
         isPartOf:
            name:Signal Transduction and Targeted Therapy
            issn:
               2059-3635
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shugang Qin
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoshan Tang
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuting Chen
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kepan Chen
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Na Fan
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wen Xiao
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qian Zheng
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guohong Li
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuqing Teng
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Min Wu
               url:http://orcid.org/0000-0003-1205-982X
               affiliation:
                     name:University of North Dakota
                     address:
                        name:Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiangrong Song
               url:http://orcid.org/0000-0002-2853-2696
               affiliation:
                     name:Sichuan University
                     address:
                        name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:mRNA-based therapeutics: powerful and versatile tools to combat diseases
      description:The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent. This represents a rising precision medicine field with great promise for preventing and treating many intractable or genetic diseases. In addition, in vitro transcribed mRNA has achieved programmed production, which is more effective, faster in design and production, as well as more flexible and cost-effective than conventional approaches that may offer. Based on these extraordinary advantages, mRNA vaccines have the characteristics of the swiftest response to large-scale outbreaks of infectious diseases, such as the currently devastating pandemic COVID-19. It has always been the scientists’ desire to improve the stability, immunogenicity, translation efficiency, and delivery system to achieve efficient and safe delivery of mRNA. Excitingly, these scientific dreams have gradually been realized with the rapid, amazing achievements of molecular biology, RNA technology, vaccinology, and nanotechnology. In this review, we comprehensively describe mRNA-based therapeutics, including their principles, manufacture, application, effects, and shortcomings. We also highlight the importance of mRNA optimization and delivery systems in successful mRNA therapeutics and discuss the key challenges and opportunities in developing these tools into powerful and versatile tools to combat many genetic, infectious, cancer, and other refractory diseases.
      datePublished:2022-05-21T00:00:00Z
      dateModified:2022-05-21T00:00:00Z
      pageStart:1
      pageEnd:35
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41392-022-01007-w
      keywords:
         Cell biology
         Molecular biology
         Medicine/Public Health
         general
         Internal Medicine
         Cancer Research
         Cell Biology
         Pathology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig9_HTML.png
      isPartOf:
         name:Signal Transduction and Targeted Therapy
         issn:
            2059-3635
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shugang Qin
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoshan Tang
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuting Chen
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kepan Chen
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Na Fan
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wen Xiao
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qian Zheng
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guohong Li
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuqing Teng
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Min Wu
            url:http://orcid.org/0000-0003-1205-982X
            affiliation:
                  name:University of North Dakota
                  address:
                     name:Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiangrong Song
            url:http://orcid.org/0000-0002-2853-2696
            affiliation:
                  name:Sichuan University
                  address:
                     name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Signal Transduction and Targeted Therapy
      issn:
         2059-3635
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:University of North Dakota
      address:
         name:Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA
         type:PostalAddress
      name:Sichuan University
      address:
         name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shugang Qin
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Xiaoshan Tang
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Yuting Chen
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Kepan Chen
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Na Fan
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Wen Xiao
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Qian Zheng
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Guohong Li
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Yuqing Teng
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Min Wu
      url:http://orcid.org/0000-0003-1205-982X
      affiliation:
            name:University of North Dakota
            address:
               name:Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA
               type:PostalAddress
            type:Organization
      name:Xiangrong Song
      url:http://orcid.org/0000-0002-2853-2696
      affiliation:
            name:Sichuan University
            address:
               name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA
      name:Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

External Links {🔗}(1976)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Particles.js
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

8.58s.